19-51350385-C-T

Variant summary

Our verdict is Likely pathogenic. The variant received 7 ACMG points: 7P and 0B. PM2PP3_StrongPP5

The NM_001985.3(ETFB):​c.382G>A​(p.Asp128Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000012 in 1,502,486 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.000026 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000010 ( 0 hom. )

Consequence

ETFB
NM_001985.3 missense

Scores

11
7

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:2U:3

Conservation

PhyloP100: 2.93

Publications

13 publications found
Variant links:
Genes affected
ETFB (HGNC:3482): (electron transfer flavoprotein subunit beta) This gene encodes electron-transfer-flavoprotein, beta polypeptide, which shuttles electrons between primary flavoprotein dehydrogenases involved in mitochondrial fatty acid and amino acid catabolism and the membrane-bound electron transfer flavoprotein ubiquinone oxidoreductase. The gene deficiencies have been implicated in type II glutaricaciduria. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2008]
ETFB Gene-Disease associations (from GenCC):
  • multiple acyl-CoA dehydrogenase deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P, PanelApp Australia

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_pathogenic. The variant received 7 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.972
PP5
Variant 19-51350385-C-T is Pathogenic according to our data. Variant chr19-51350385-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 16718.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001985.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ETFB
NM_001985.3
MANE Select
c.382G>Ap.Asp128Asn
missense
Exon 4 of 6NP_001976.1
ETFB
NM_001014763.1
c.655G>Ap.Asp219Asn
missense
Exon 3 of 5NP_001014763.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ETFB
ENST00000309244.9
TSL:1 MANE Select
c.382G>Ap.Asp128Asn
missense
Exon 4 of 6ENSP00000311930.3
ETFB
ENST00000354232.8
TSL:1
c.655G>Ap.Asp219Asn
missense
Exon 3 of 5ENSP00000346173.3
ENSG00000269403
ENST00000600067.1
TSL:5
n.*308G>A
non_coding_transcript_exon
Exon 4 of 4ENSP00000469452.1

Frequencies

GnomAD3 genomes
AF:
0.0000263
AC:
4
AN:
152168
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000168
AC:
4
AN:
238180
AF XY:
0.0000233
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000375
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000104
AC:
14
AN:
1350200
Hom.:
0
Cov.:
21
AF XY:
0.0000103
AC XY:
7
AN XY:
676680
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31384
American (AMR)
AF:
0.00
AC:
0
AN:
43758
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25170
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39170
South Asian (SAS)
AF:
0.00
AC:
0
AN:
82634
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52658
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5538
European-Non Finnish (NFE)
AF:
0.0000128
AC:
13
AN:
1013194
Other (OTH)
AF:
0.0000176
AC:
1
AN:
56694
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000263
AC:
4
AN:
152286
Hom.:
0
Cov.:
32
AF XY:
0.0000403
AC XY:
3
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.0000481
AC:
2
AN:
41554
American (AMR)
AF:
0.00
AC:
0
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10606
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68030
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.550
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000346
Hom.:
0
Bravo
AF:
0.00000756
ExAC
AF:
0.00000824
AC:
1

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:2Uncertain:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Multiple acyl-CoA dehydrogenase deficiency Pathogenic:1Uncertain:2
Dec 15, 2021
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 128 of the ETFB protein (p.Asp128Asn). This variant is present in population databases (rs104894678, gnomAD 0.004%). This missense change has been observed in individual(s) with multiple acyl-CoA dehydrogenase deficiency (PMID: 12815589). ClinVar contains an entry for this variant (Variation ID: 16718). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C15"). Experimental studies have shown that this missense change affects ETFB function (PMID: 12815589). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

Aug 24, 2022
Revvity Omics, Revvity
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Dec 06, 2023
Baylor Genetics
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Glutaric acidemia IIb Pathogenic:1
Jul 01, 2003
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

not specified Uncertain:1
Mar 28, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: ETFB c.382G>A (p.Asp128Asn) results in a conservative amino acid change located in the Electron transfer flavoprotein, alpha/beta-subunit, N-terminal domain (IPR014730) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.7e-05 in 238180 control chromosomes (gnomAD). c.382G>A has been reported in the literature in a homozygous individual affected with multiple acyl-CoA dehydrogenase deficiency type 3 (Olsen_2003). These data indicate that the variant may be associated with disease. Publications report experimental evidence evaluating an impact on protein function (Henriques_2009, 2010, Rodrigues_2012), finding that the variant results in partially reduced ETFB activity. The following publications have been ascertained in the context of this evaluation (PMID: 12815589, 19088074, 20674745, 22588007). ClinVar contains an entry for this variant (Variation ID: 16718). Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.95
BayesDel_addAF
Uncertain
0.048
T
BayesDel_noAF
Uncertain
-0.060
CADD
Pathogenic
33
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.80
D
Eigen
Pathogenic
0.71
Eigen_PC
Uncertain
0.59
FATHMM_MKL
Uncertain
0.82
D
LIST_S2
Pathogenic
1.0
D
M_CAP
Pathogenic
0.53
D
MetaRNN
Pathogenic
0.97
D
MetaSVM
Pathogenic
0.88
D
MutationAssessor
Pathogenic
4.5
H
PhyloP100
2.9
PrimateAI
Uncertain
0.71
T
PROVEAN
Pathogenic
-4.8
D
REVEL
Pathogenic
0.83
Sift
Uncertain
0.0020
D
Sift4G
Pathogenic
0.0010
D
Polyphen
0.96
D
Vest4
0.89
MutPred
0.92
Loss of ubiquitination at K124 (P = 0.1099)
MVP
0.98
MPC
0.29
ClinPred
0.99
D
GERP RS
3.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.96
gMVP
0.92
Mutation Taster
=19/81
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.090
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs104894678; hg19: chr19-51853639; API